A detailed history of Hrt Financial LP transactions in Liquidia Corp stock. As of the latest transaction made, Hrt Financial LP holds 10,886 shares of LQDA stock, worth $119,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,886
Holding current value
$119,854
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$11.96 - $15.71 $130,196 - $171,019
10,886 New
10,886 $130,000
Q2 2023

Aug 11, 2023

BUY
$6.63 - $9.9 $106,703 - $159,330
16,094 Added 20.24%
95,619 $750,000
Q1 2023

May 12, 2023

BUY
$5.72 - $7.91 $454,883 - $629,042
79,525 New
79,525 $549,000
Q4 2021

Feb 14, 2022

SELL
$2.71 - $5.17 $141,204 - $269,382
-52,105 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.28 - $2.95 $44,450 - $57,513
19,496 Added 59.79%
52,105 $143,000
Q2 2021

Aug 16, 2021

BUY
$2.51 - $3.11 $81,848 - $101,413
32,609 New
32,609 $93,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.